Prostate cancer screening — MCCQE Part 1 MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Discuss potential benefits and harms before deciding on PSA screening
Canadian guidance favours shared decision-making for PSA testing rather than routine population screening. The patient should understand false positives, overdiagnosis, biopsy harms, and uncertain mortality benefit. PSA testing is not prohibited, but it should not be automatic. MRI and finasteride are not first-line population screening/prevention strategies.
Reference: CTFPHC prostate cancer screening guidance; Canadian Urological Association